ALFA Finder| Revenue growth | FY26 revenue up 42% YoY to ₹173.5cr. |
|---|---|
| Margins | EBITDA margin 20% in FY26; targeting 22% FY27 and 23-25% FY28. |
| Demand visibility | Strong; 10 neighboring districts targeted; cancer hospital utilization at 42%. |
| Management confidence | High; described FY27 targets as aggressive but achievable through built systems. |
Growth
FY26 consolidated revenue grew 42% to ₹173.5cr; PAT surged 58% to ₹16.7cr. FY26 EBITDA margin held at 20%.
Outlook
FY27 revenue target ₹260cr; long-term FY28 target ₹400cr revenue with 23-25% EBITDA margins; plans to reach 1,000 beds by FY30.
Risks
Regulatory delays in organ transplant approvals; high dependency on government schemes (Ayushman Bharat) affecting cash realization and aging.
Earnings Call filed with BSE, BSE: 543943. Summary written with AI assistance from the document.
Asarfi Hospital Ltd: key numbers
- Share price
- ₹183.00
- Market cap
- ₹360.1 Cr
- Revenue (annual)
- ₹173.5 Cr
- Net profit (annual)
- ₹16.66 Cr
- P/E (TTM)
- 21.6×Sector 35.3×
- Promoter holding
- 61.18%+0.01% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Asarfi Hospital Ltd
All →Asarfi Hospital Other Announcement
Asarfi Hospital Limited filed its half-yearly shareholding pattern under Regulation 31(1)(b) for the period ended 30 September 2026. The filing shows promoter and public holdings, with no transaction or corporate event.
Asarfi Hospital Other Announcement
Asarfi Hospital Ltd has filed its shareholding pattern for the quarter ended September 30, 2026. This disclosure outlines the current distribution of equity shares.
Asarfi Hospital Credit Rating
Asarfi Hospital Ltd announced that CRISIL Ratings upgraded its bank facilities credit rating. The total rated bank facilities are now ₹60 Crore, enhanced from ₹46.5 Crore.
- Value
- ₹60.00 Cr
Asarfi Hospital Annual General Meeting
Asarfi Hospital Ltd's 21st Annual General Meeting held on September 18, 2026, saw shareholder approval for financial statements, director reappointment, and migration to the BSE Main Board.
Asarfi Hospital Annual Report
Asarfi Hospital Limited has submitted its Annual Report for the Financial Year 2025-26 in compliance with SEBI Listing Regulations.
Asarfi Hospital Other Announcement
Asarfi Hospital Limited has appointed M/s Ashutosh Kumar Sinha & Co as the Cost Auditor for the financial year 2026-27, as approved by the Board.